Fox Chase Cancer Center News

PHILADELPHIA (April 16, 2021)—Colleen H. Tetzlaff, MHS, PA-C, advanced practice clinician in the Department of Hematology/Oncology at Fox Chase Cancer Center, has been recognized as the recipient of the first-ever Sharon Schwartz Award, which is presented by the Recognition and Development Model (RDM) Committee at Fox Chase.

PHILADELPHIA (April 14, 2021) – In a study published today, researchers at Fox Chase Cancer Center announced that they have discovered a novel approach to triggering a type of cancer cell death called ferroptosis that could have therapeutic potential.

PHILADELPHIA (April 9, 2021)— During a poster session at this year’s American Association for Cancer Research (AACR) Annual Meeting Part 1, researchers at Fox Chase Cancer Center will present findings from a recent study on predicting therapy response in locally advanced rectal cancer patients.

PHILADELPHIA (April 9, 2021)— During a poster session at this year’s American Association for Cancer Research (AACR) Annual Meeting Part 1, researchers at Fox Chase Cancer Center will present findings from a recent study on predicting therapy response in locally advanced rectal cancer patients.

PHILADELPHIA (April 8, 2021)—A study from researchers at Fox Chase Cancer Center has shown that while complication rates differ among methods of reconstructive breast surgery, both implants and autologous methods that use a patient’s own tissue are safe options.

PHILADELPHIA (April 7, 2021)—In a recent study, researchers at Fox Chase Cancer Center identified several factors that may accurately predict the presence of malignant cells in pancreatic cancer patients who undergo a peritoneal washing.

PHILADELPHIA (April 7, 2021)—Fox Chase Cancer Center was recently awarded Tobacco Treatment Program Supplements from the National Cancer Institute to support the expansion of current services for patients who use tobacco. 

PHILADELPHIA (MARCH 30, 2021)—There’s more and more evidence that genes associated with one type of cancer may increase risk for other cancers as well. Now a study by Fox Chase Cancer Center scientists quantifies new risks for pancreatic, prostate, gastric, and other cancer in a gene previously linked to breast cancer.